| 1 |
34969765 | Olaparib-induced Apoptosis Through EBNA1-ATR-p38 MAPK Signaling Pathway in Epstein-Barr Virus-positive Gastric Cancer Cells. | 2022 Jan |
4 |
| 2 |
35051747 | Recent advances in DDR (DNA damage response) inhibitors for cancer therapy. | 2022 Feb 15 |
1 |
| 3 |
35078817 | ATR Inhibitor AZD6738 (Ceralasertib) Exerts Antitumor Activity as a Monotherapy and in Combination with Chemotherapy and the PARP Inhibitor Olaparib. | 2022 Mar 15 |
1 |
| 4 |
33268569 | Combinatorial Efficacy of Olaparib with Radiation and ATR Inhibitor Requires PARP1 Protein in Homologous Recombination-Proficient Pancreatic Cancer. | 2021 Feb |
2 |
| 5 |
34082024 | ATR inhibition amplifies antitumor effects of olaparib in biliary tract cancer. | 2021 Sep 28 |
2 |
| 6 |
34280886 | MTA2 sensitizes gastric cancer cells to PARP inhibition by induction of DNA replication stress. | 2021 Oct |
1 |
| 7 |
34527850 | Ceralasertib-Mediated ATR Inhibition Combined With Olaparib in Advanced Cancers Harboring DNA Damage Response and Repair Alterations (Olaparib Combinations). | 2021 |
1 |
| 8 |
34761497 | MET inhibition enhances PARP inhibitor efficacy in castration-resistant prostate cancer by suppressing the ATM/ATR and PI3K/AKT pathways. | 2021 Dec |
1 |
| 9 |
34944835 | Increased Replication Stress Determines ATR Inhibitor Sensitivity in Neuroblastoma Cells. | 2021 Dec 10 |
2 |
| 10 |
33352723 | PARP Inhibition Increases the Reliance on ATR/CHK1 Checkpoint Signaling Leading to Synthetic Lethality-An Alternative Treatment Strategy for Epithelial Ovarian Cancer Cells Independent from HR Effectiveness. | 2020 Dec 19 |
3 |
| 11 |
31529615 | Premature mitotic entry induced by ATR inhibition potentiates olaparib inhibition-mediated genomic instability, inflammatory signaling, and cytotoxicity in BRCA2-deficient cancer cells. | 2019 Nov |
4 |
| 12 |
26097887 | A quasi-quantitative dual multiplexed immunoblot method to simultaneously analyze ATM and H2AX Phosphorylation in human peripheral blood mononuclear cells. | 2015 |
1 |